In a different study that analysed biopsies from 1134 endometrial cancer patients, L1CAM high expression predicted poor disease-specific survival – defined as time from surgery to death – both in the entire cohort and among low-risk patients, who normally receive no or limited adjuvant treatment [57]. Here, L1CAM is linked to endometrial cancer.